An inoculation site-retained mRNA vaccine induces robust immune responses against SARS-CoV-2 variants
Lei Huang(Fudan University), Haifa Shen(Houston Methodist), Entao Li(University of Science and Technology of China), Bo Yu(Pudong Medical Center), Hangwen Li(Shanghai East Hospital), Hanfei Zhu, Shuaiyao Lu(Chinese Academy of Medical Sciences & Peking Union Medical College), Dong Zhao(Beijing University of Chemical Technology), Chao Wang(Soochow University), Jie Wang(Tongji University), Fanfan Zhao, Xueli Wang, Yuwei Gao(Changchun University of Chinese Medicine), Yi Fang(Second Affiliated Hospital of Nanjing Medical University), Siyuan Tang, Muye He, Xiaozhong Peng(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaoping Ma, Hui Xiao(Kunming University of Science and Technology)
Cited by 20
Related Papers
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
|eLife|2012|2.1k
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
|Nature Medicine|2011|1.4k
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
|Nature|2020|1.2k
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
|Nature|2020|849
Delivery of siRNA Therapeutics: Barriers and Carriers
|The AAPS Journal|2010|787